Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Whitehawk Therapeutics (WHWK) Debt to Equity (2021)

Whitehawk Therapeutics (WHWK) has disclosed Debt to Equity for 1 consecutive years, with $0.04 as the latest value for Q4 2021.

  • Quarterly Debt to Equity changed N/A to $0.04 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $0.04 through Dec 2021, changed N/A year-over-year, with the annual reading at $0.04 for FY2021, N/A changed from the prior year.
  • Debt to Equity for Q4 2021 was $0.04 at Whitehawk Therapeutics, up from $0.04 in the prior quarter.
  • The five-year high for Debt to Equity was $0.04 in Q4 2021, with the low at $0.04 in Q3 2021.